2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Status
Unknown
1
Completed
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Other hematologic neoplasm
1
Conditions
Febrile Neutropenia
7
Neoplasms
5
Hematologic Neoplasms
3
Neutropenia
2
Fever
2
Urinary Bladder Neoplasms
1
Sepsis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Other Infectious Diseases
1
Leukemia, Myeloid, Acute
1
Emergencies
1
Interventions
Vancomycin
4
pegfilgrastim
3
Cefepime
3
trametinib
2
liposomal amphotericin B
2
dabrafenib
2
Piperacillin, Tazobactam Drug Combination
2
Meropenem
2
Filgrastim
2
Ciprofloxacin
2
Ceftazidime
2
Caspofungin
2
ofatumumab
1
ceftobiprole medocaril
1
Teicoplanin
1
Tazobactam
1
Surveys and Questionnaires
1
Ritonavir
1
Quality of Life
1
Povidone-Iodine
1
Piperacillin
1
Moxifloxacin
1
Metformin
1
Mannose-Binding Lectin
1
Levofloxacin
1
Lenalidomide
1
Itraconazole
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Granulocyte Colony-Stimulating Factor
1
Doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Fever
×
Meropenem
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled
NCT02463747
2015-06-04
RR
Tel-Aviv Sourasky Medical Center
Phase 4
Unknown
110 enrolled